4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Anika Therapeutics, Inc. (ANIK) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Bedford, United States with about 235 employees. Its market capitalization is roughly $199 million. In the fiscal year ended 2025-12-31, ANIK reported $113M in revenue and ($11M) in net income.
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.
Interactive charts & full statements → Open the ANIK valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $113M | $120M | $121M | $114M | — |
| Gross Profit | $64M | $76M | $82M | $73M | — |
| Operating Income (EBIT) | ($11M) | ($5M) | $1M | $4M | — |
| Net Income | ($11M) | ($56M) | ($83M) | ($15M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $30M | $31M | $28M | $28M | $26M |
| Gross Profit | $19M | $19M | $16M | $14M | $15M |
| Operating Income (EBIT) | ($6M) | $1M | ($3M) | ($4M) | ($4M) |
| Net Income | ($5M) | $0M | ($2M) | ($4M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $190M | $203M | $271M | $349M | — |
| Total Liabilities | $47M | $49M | $58M | $64M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANIK viewer.
About TickerBase · Data methodology & sources